靶向P2X7受体的放射性配体[18F]GSK1482160用于强直性脊柱炎PET显像与定量
本研究基于亲核脂肪族取代制备靶向P2X7受体的18F标记示踪剂[18F]GSK1482160,对强直性脊柱炎(AS)小鼠(n=8)与年龄匹配对照(n=8)行动态micro-PET/CT显像,采用Logan图形动脉输入函数分析定量P2X7R体内表达。结果显示AS小鼠踝关节与骶髂关节特异性结合显著高于对照,而[18F]FDG摄取四组间无显著差异,P2X7R过表达与活化巨噬细胞共定位。
要点
- AS小鼠踝关节与骶髂关节[18F]GSK1482160特异性结合显著高于对照组
- 四组间踝关节与骶髂关节[18F]FDG摄取无显著差异
- P2X7R过表达与踝关节滑膜及脊柱终板活化巨噬细胞共定位
核心结论
- 本研究开发了靶向P2X7R的新型PET示踪剂[18F]GSK1482160,可在AS小鼠模型中检测P2X7R表达,并为AS提供有力的无创PET显像与定量手段。
研究设计与样本
- 研究经亲核脂肪族取代制备放射性配体[18F]GSK1482160,对AS小鼠(n=8)与年龄匹配对照(n=8)行动态[18F]GSK1482160及[18F]FDG micro-PET/CT显像。
- 采用Logan图形动脉输入函数分析进行示踪剂动力学建模,以定量P2X7R体内表达。
- PET后采集组织行苏木精-伊红(H&E)、免疫组织化学(IHC)与免疫荧光(IF)染色。
主要发现
- AS 8周组踝关节不可置换结合势BPND为3.931±0.74、骶髂关节为4.225±0.84,分别显著高于对照8周组的踝关节0.325±0.15与骶髂关节0.319±0.17。
- AS 14周组踝关节BPND为12.212±2.25、骶髂关节为13.389±3.60,分别显著高于对照14周组的踝关节0.204±0.16与骶髂关节0.655±0.35。
- 四组间踝关节与骶髂关节的[18F]FDG摄取无显著差异。
- IHC与IF染色显示,AS小鼠P2X7R过表达与踝关节滑膜及脊柱终板的活化巨噬细胞共定位,提示P2X7R定量可能有助于理解人AS炎症的发病机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial spine; however, the quantitative detection of inflammation in AS remains a challenge in clinical settings. We aimed to investigate the feasibility of using a specific P2X7R-targeting 18F-labeled tracer [18F]GSK1482160 for positron emission tomography (PET) imaging and the quantification of AS. METHODS: The radioligand [18F]GSK1482160 was obtained based on nucleophilic aliphatic substitution. Dynamic [18F]GSK1482160 and [18F]FDG micro-PET/CT imaging were performed on AS mice (n = 8) and age-matched controls (n = 8). Tracer kinetics modeling was performed using Logan's graphical arterial input function analysis to quantify the in vivo expression of P2X7R. The post-PET tissues were collected for hematoxylin-eosin (H&E), immunohistochemical (IHC), and immunofluorescence (IF) staining. RESULTS: [18F]GSK1482160 PET/CT imaging revealed that the specific binding in the ankle joint and sacroiliac joint (SIJ) of the AS at 8 weeks group (BPNDankle-AS-8W (non-displaceable binding potential of the ankle) 3.931 ± 0.74; BPND SIJ-AS-8W (BPBD of the SIJ) 4.225 ± 0.84) were significantly higher than the controls at 8 weeks group (BPNDankle-Ctr-8W 0.325 ± 0.15, BPNDSJJ-Ctr-8W 0.319 ± 0.17) respectively, and the AS at 14 weeks group (BPNDankle-AS-14W 12.212 ± 2.25; BPNDSJJ-AS-14W 13.389 ± 3.60) were significantly higher than the controls at 14 weeks group (BPNDankle-Ctr-14W 0.204 ± 0.16, BPNDSJJ-Ctr-14W 0.655 ± 0.35) respectively. The four groups had no significant difference in the [18F]FDG uptake of ankle and SIJ. IHC and IF staining revealed that the overexpression of P2X7R was colocalized with activated macrophages from the ankle synovium and spinal endplate in mice with AS, indicating that quantification of P2X7R may contribute to the understanding of the pathogenesis of inflammation in human AS. CONCLUSION: This study developed a novel P2X7R-targeting PET tracer [18F]GSK1482160 to detect the expression of P2X7R in AS mouse models and provided powerful non-invasive PET imaging and quantification for AS.
引用
- Zhang S, Qiu Y, Huang L, et al. Ankylosing spondylitis PET imaging and quantifications via P2X7 receptor-targeting radioligand [18F]GSK1482160. Eur J Nucl Med Mol Imaging. 2023. PMID: 37466648. doi:10.1007/s00259-023-06342-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。